$438.12▴ 1.92%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
Fair value
Fairly valued
Trading right around our fair-value range
Value-trap risk
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
Amgen Inc.'s earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days21 articles
9 bullish12 neutral0 bearish
Which iShares Healthcare ETF Is the Better Buy: Biotech-Focused IBB or Broad IYH?
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends?
A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That Happens
Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy?Coronary Artery Disease Clinical Trial Space Intensifies with 20+ Companies in Active Development | DelveInsight